Alphabetical listing of all products

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Prices
  • 5 mg - 194 EUR
  • 25 mg - 776 EUR
  • 100 mg - 2328 EUR

Telatinib

Telatinib is an orally active small-molecule tyrosine kinase inhibitor that targets the kinase insert domain receptor (KDR; VEGFR-2) and the fms-related tyrosine kinase 4 (FLT4; VEGFR-3). Treatment with Telatinib inhibits angiogenesis and cellular proliferation in tumors in which these receptors are upregulated.

catalogue number: T112
synonyms: BAY 57-9352
CAS: 332012-40-5
MW: 409.83 g/mol

References
Invest New Drugs. 2011 Feb;29(1):137-43. PMID: 19924384